Singapore markets closed

SELLAS Life Sciences Group, Inc. (SLS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5200-0.0200 (-1.30%)
At close: 04:00PM EDT
1.5000 -0.02 (-1.32%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,000
0
1,000
7,600
1,900
Cost of revenue
100
0
100
200
0
Gross profit
900
0
900
7,400
1,900
Operating expenses
Research development
33,515
24,007
20,268
15,674
9,282
Selling general and administrative
11,508
13,862
12,582
11,320
9,600
Total operating expenses
45,023
37,869
32,850
26,994
18,882
Operating income or loss
-44,123
-37,869
-31,950
-19,594
-16,982
Total other income/expenses net
4,949
4
-9,668
-1,348
182
Income before tax
-39,015
-37,340
-41,301
-20,936
-16,774
Income tax expense
-
-
0
-237
-17
Income from continuing operations
-38,778
-37,340
-41,301
-20,699
-16,757
Net income
-38,778
-37,340
-41,301
-20,699
-16,757
Net income available to common shareholders
-38,778
-37,340
-41,301
-20,699
-16,835
Basic EPS
-1.52
-
-2.13
-1.34
-2.11
Diluted EPS
-1.52
-
-2.13
-1.34
-2.11
Basic average shares
25,272
-
19,396
15,481
7,977
Diluted average shares
25,272
-
19,396
15,481
7,977